BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32553981)

  • 1. Quantitative and network pharmacology: A case study of rhein alleviating pathological progress of renal interstitial fibrosis.
    Shen Y; Feng F; Sun H; Li G; Xiang Z
    J Ethnopharmacol; 2020 Oct; 261():113106. PubMed ID: 32553981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated network pharmacology and cell metabolomics approach to reveal the role of rhein, a novel PPARα agonist, against renal fibrosis by activating the PPARα-CPT1A axis.
    Xiao Q; Yu X; Yu X; Liu S; Jiang J; Cheng Y; Lin H; Wang Y; Zhang X; Ye X; Xiang Z
    Phytomedicine; 2022 Jul; 102():154147. PubMed ID: 35567992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norcantharidin protects against renal interstitial fibrosis by suppressing TWEAK-mediated Smad3 phosphorylation.
    Zeng D; Xiao Z; Xu Q; Luo H; Wen L; Tang C; Shan Y; Tian J; Wei J; Li Y
    Life Sci; 2020 Nov; 260():118488. PubMed ID: 32979359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats.
    Wang FM; Yang YJ; Ma LL; Tian XJ; He YQ
    Nephrology (Carlton); 2014 Sep; 19(9):542-51. PubMed ID: 24754438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway.
    Dou F; Ding Y; Wang C; Duan J; Wang W; Xu H; Zhao X; Wang J; Wen A
    Biochem Pharmacol; 2020 Oct; 180():114079. PubMed ID: 32511988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic allograft nephropathy in rats is improved by the intervention of rhein.
    Su J; Yin LP; Zhang X; Li BB; Liu L; Li H
    Transplant Proc; 2013; 45(6):2546-52. PubMed ID: 23953579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effects and mechanisms of rhein on renal interstitial fibrosis in obstructive nephropathy.
    He D; Lee L; Yang J; Wang X
    Biol Pharm Bull; 2011; 34(8):1219-26. PubMed ID: 21804209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
    Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
    J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling.
    Zhu Y; Yu C; Zhuang S
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F375-F387. PubMed ID: 31813251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology.
    Xiang Z; Sun H; Cai X; Chen D; Zheng X
    Mol Biosyst; 2015 Apr; 11(4):1067-78. PubMed ID: 25630238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.
    Li R; Chung AC; Dong Y; Yang W; Zhong X; Lan HY
    Kidney Int; 2013 Dec; 84(6):1129-44. PubMed ID: 23868013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elsholtzia ciliata (Thunb.) Hylander attenuates renal inflammation and interstitial fibrosis via regulation of TGF-ß and Smad3 expression on unilateral ureteral obstruction rat model.
    Kim TW; Kim YJ; Seo CS; Kim HT; Park SR; Lee MY; Jung JY
    Phytomedicine; 2016 Apr; 23(4):331-9. PubMed ID: 27002403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation into the effect and mechanism of dapagliflozin against renal interstitial fibrosis based on transcriptome and network pharmacology.
    Liu Y; Wang Y; Chen S; Bai L; Xie X; Zhang L; Wang X
    Int Immunopharmacol; 2022 Nov; 112():109195. PubMed ID: 36070627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
    Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics study of rhein treating renal fibrosis based on metabonomics approach.
    Sun H; Luo G; Xiang Z; Cai X; Chen D
    Phytomedicine; 2016 Dec; 23(13):1661-1670. PubMed ID: 27823631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhein Inhibits Autophagy in Rat Renal Tubular Cells by Regulation of AMPK/mTOR Signaling.
    Tu Y; Gu L; Chen D; Wu W; Liu H; Hu H; Wan Y; Sun W
    Sci Rep; 2017 Mar; 7():43790. PubMed ID: 28252052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhein alleviates renal interstitial fibrosis by inhibiting tubular cell apoptosis in rats.
    Chen Y; Mu L; Xing L; Li S; Fu S
    Biol Res; 2019 Sep; 52(1):50. PubMed ID: 31492196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HOTAIR promotes renal interstitial fibrosis by regulating Notch1 pathway via the modulation of miR-124.
    Zhou H; Gao L; Yu ZH; Hong SJ; Zhang ZW; Qiu ZZ
    Nephrology (Carlton); 2019 Apr; 24(4):472-480. PubMed ID: 29717517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential signal pathway between PAX2 and CD2AP in the renal interstitial fibrosis disease.
    Xu HL; Ou C; Rong L; Zhou TB
    J Recept Signal Transduct Res; 2014 Aug; 34(4):290-8. PubMed ID: 24471428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis.
    Chen DQ; Wang YN; Vaziri ND; Chen L; Hu HH; Zhao YY
    Phytomedicine; 2020 Jul; 72():153232. PubMed ID: 32460034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.